 |
|
recombinant human endostatin
A recombinant human proteolytic fragment of the C-terminal end of type XVIII collagen. Endostatin induces microvascular endothelial cell apoptosis and inhibits endothelial proliferation and angiogenesis, which may result in a reduction in tumor burden. This agent also may decrease hepatic metastasis by inhibiting proinflammatory cytokines and vascular cell adhesion molecule (VCAM)-dependent cell attachment to the hepatic microvasculature. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | rhEndostatin | | |
|
|
